… , a combined case–control and follow-up study was conducted … aortic pathology (aortic
dissection, thoracic or thoracoabdominal … Angiotensin converting enzyme inhibitors and ARBs are …

… The search strategy was: “(angiotensin converting enzyme OR ACE inhibitor OR ACE OR
angiotensin … enzyme inhibitors and aortic rupture: a population-based case–control study. …

… from the population-based Heinz Nixdorf Recall Study with … (0.63 [0.48–0.83]),
angiotensin-converting enzyme inhibitors (… Our analysis of the risk factors for IA rupture included …

… Using nationwide data sources, a retrospective population based case control study of … :
thiazide, calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin II …

… Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control
study. Lancet 2006;… Angiotensin-converting enzyme inhibitors and angiotensin II receptor …

… A case–control study on a group of over 15 000 … an angiotensin-converting enzyme inhibitor
(ACE-I) but not other anti-hypertensive agents were 20% less likely to present with ruptured …

… diseases, including aortic root dilatation, thoracic aneurysm and aortic dissection.1 2 The …
use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers between …

Various pedagogical models have been introduced in an attempt to improve and restructure
surgical training, but significant obstacles remain. Before implementing national guidelines, …

… -blocker, angiotensin-converting-enzyme (ACE) inhibitor or … In this retrospective, nested-case
control study, we … rate in abdominal AA patients in a population-based study [25]. They also …

… A nested case–control study demonstrated that the adjusted odds ratio (OR) of AA and
AD for any indicated infection was 1.73 (95% CI, 1.66–1.81) 17 ; moreover, this study did not …